One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B post-liver transplantation
about
Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.Recent advances in prevention of hepatitis B recurrence after liver transplantation.Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation.Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin.Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma.Comparative efficacy of oral nucleotide analogues for the prophylaxis of hepatitis B virus recurrence after liver transplantation: a network meta-analysis.Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients.Efficacy of tenofovir disoproxil fumarate therapy in Chinese chronic hepatitis B patients after multiple antiviral failures.New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.Hepatitis B virus treatment in hepatocellular carcinoma patients prolongs survival and reduces the risk of cancer recurrence
P2860
Q35715908-088341EE-CF28-4CBC-8041-F4DC17D8578AQ38333875-22705201-B6DF-4CC6-95B4-4CF844FEA53AQ38417238-CC698EBC-D57F-42D2-A25B-6E8E06081B1BQ38514411-103458FF-D27C-408C-91D4-133FBAAE929CQ38665203-601D0FA6-D588-473C-B889-A84EC6D36F1BQ40588229-6DC47A8E-5943-4A7A-95BF-191AE3DB6702Q40851895-217ECFA8-8B14-470C-B405-0DEB537446DAQ41062056-EE21EDE8-E78A-4020-97F0-232F09135536Q41645626-F4505CB7-592F-4689-BA6F-0A5102A9BC51Q42213645-94362B0C-F50C-40FA-899A-AA7AB9C4D72BQ57494336-98CA9156-96E5-41B1-925A-C9C814A2D22F
P2860
One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B post-liver transplantation
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
One year of hepatitis B immuno ...... s B post-liver transplantation
@ast
One year of hepatitis B immuno ...... s B post-liver transplantation
@en
type
label
One year of hepatitis B immuno ...... s B post-liver transplantation
@ast
One year of hepatitis B immuno ...... s B post-liver transplantation
@en
prefLabel
One year of hepatitis B immuno ...... s B post-liver transplantation
@ast
One year of hepatitis B immuno ...... s B post-liver transplantation
@en
P2093
P2860
P356
P1476
One year of hepatitis B immuno ...... s B post-liver transplantation
@en
P2093
Eberhard L Renner
George Therapondos
Leslie B Lilly
Nazia Selzner
Tomohiro Tanaka
P2860
P356
10.1155/2014/839014
P407
P577
2013-11-08T00:00:00Z